Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial.
Bertrand D, Joly J, Neerinckx B, Durez P, Lenaerts J, Joos R, Thevissen K, Zwaenepoel T, Vanhoof J, Di Romana S, Taelman V, Van Essche E, Corluy L, Ribbens C, Vanden Berghe M, Devinck M, Ajeganova S, Durnez A, Boutsen Y, Margaux J, Peene I, Van Offel J, Doumen M, Pazmino S, De Meyst E, Kulyk M, Creten N, Westhovens R, Verschueren P; CareRA2020 Study group. Bertrand D, et al. RMD Open. 2024 Aug 7;10(3):e004535. doi: 10.1136/rmdopen-2024-004535. RMD Open. 2024. PMID: 39117445 Free PMC article. Clinical Trial.
A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis.
De Cock D, Brants L, Soenen I, Pazmino S, Bertrand D, Stouten V, Westhovens R, Verschueren P. De Cock D, et al. Among authors: bertrand d. Semin Arthritis Rheum. 2020 Oct;50(5):873-878. doi: 10.1016/j.semarthrit.2020.07.003. Epub 2020 Aug 30. Semin Arthritis Rheum. 2020. PMID: 32896703 Review.
Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial.
Stouten V, Westhovens R, De Cock D, Van der Elst K, Pazmino S, Bertrand D, Joly J, Verschueren P. Stouten V, et al. Among authors: bertrand d. Rheumatology (Oxford). 2021 Aug 2;60(8):3699-3708. doi: 10.1093/rheumatology/keaa841. Rheumatology (Oxford). 2021. PMID: 33434277 Clinical Trial.
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial.
Pazmino S, Boonen A, De Cock D, Stouten V, Joly J, Bertrand D, Westhovens R, Verschueren P. Pazmino S, et al. Among authors: bertrand d. RMD Open. 2021 May;7(2):e001615. doi: 10.1136/rmdopen-2021-001615. RMD Open. 2021. PMID: 34031262 Free PMC article. Clinical Trial.
Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study.
Stouten V, Pazmino S, Verschueren P, Mamouris P, Westhovens R, de Vlam K, Bertrand D, Van der Elst K, Vaes B, De Cock D. Stouten V, et al. Among authors: bertrand d. RMD Open. 2021 Jun;7(2):e001671. doi: 10.1136/rmdopen-2021-001671. RMD Open. 2021. PMID: 34158353 Free PMC article.
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir et al.
Stouten V, Westhovens R, Pazmino S, De Cock D, Van der Elst K, Joly J, Bertrand D, Verschueren P. Stouten V, et al. Among authors: bertrand d. Ann Rheum Dis. 2023 Jul;82(7):e163. doi: 10.1136/annrheumdis-2021-220857. Epub 2021 Jun 30. Ann Rheum Dis. 2023. PMID: 34193403 No abstract available.
738 results